<DOC>
	<DOCNO>NCT01960413</DOCNO>
	<brief_summary>In feasibility trial , investigator compare participant treat montelukast hydroxyurea treat placebo hydroxyurea total 8 week .</brief_summary>
	<brief_title>Phase 2 Study Montelukast Treatment Sickle Cell Anemia</brief_title>
	<detailed_description>The primary hypothesis trial montelukast add efficacy hydroxyurea therapy improve vaso-occlusion compare hydroxyurea alone . The follow specific aim test adolescent adult sickle cell disease : Aim 1 . To determine whether montelukast versus placebo add hydroxyurea improve marker vaso-occlusion-associated tissue injury adolescent adult sickle cell disease . Aim 2 . To evaluate physiologic effect montelukast versus placebo add hydroxyurea adolescent adult sickle cell disease . Subaim 2A . To determine montelukast versus placebo add hydroxyurea improve lung function adolescent adult sickle cell disease . Subaim 2B . To determine montelukast versus placebo add hydroxyurea improve forearm microvascular blood flow adolescent adult sickle cell disease , respectively . Funding Source - FDA OOPD</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>1 ) Diagnosis HbSS , HbSÎ²thalassemia0 , confirm hemoglobin analysis 2 ) Males females age 16 year 70 year old 3 ) Greater 2 episode pain last 12 month 4 ) On stable dose hydroxyurea least 2 month stable hemoglobin 1 . Judged likely study compliant his/her hematologist 2 . History adverse reaction montelukast component montelukast 3 . Have use medication know interact montelukast rifampin , phenobarbital , gemfibrozil within 4 week enrollment 4 . Currently treat leukotriene antagonist ( montelukast zileuton ) use montelukast/zileuton within last 60 day 5 . Chronic blood transfusion therapy define regularly schedule transfusion . 6 . Hemoglobin A great than15 % hemoglobin analysis 7 . Individuals current physician diagnosis asthma ( within last 12 month ) require continuous supplemental oxygen , predict current use asthma medication ( inhaled corticosteroid , participant take bronchodilator allow participate ) . 8 . Current participation another therapeutic trial SCD 9 . Known current pregnancy 10 . Known history HIV 11 . Serum creatinine great 3 time site 's upper limit normal</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>